Literature DB >> 5883513

In vitro and in vivo laboratory comparison of cephalothin and desacetylcephalothin.

W E Wick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5883513

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  13 in total

1.  The role of the kidney in the elimination of cephapirin in man.

Authors:  B E Cabana; D R Van Harken; G H Hottendorf; J T Doluisio; W O Griffen; D W Bourne; L W Dittert
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.

Authors:  P F Sonneville; R R Kartodirdjo; H Skeggs; A E Till; C M Martin
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

3.  Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin.

Authors:  C S Goodwin; E B Raftery; A D Goldberg; H Skeggs; A E Till; C M Martin
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

4.  Chemoprophylaxis with cefoxitin and cephalothin in orthopedic surgery: a comparison.

Authors:  M B Rosenfeld; J Campos; K R Ratzan; I Uredo
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

5.  Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria.

Authors:  J P O'Keefe; K A Troc; K D Thompson
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.

Authors:  J G Christenson; K K Chan; R Cleeland; B Dix-Holzknecht; H H Farrish; I H Patel; A Specian
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

7.  Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.

Authors:  P F Sonneville; K S Albert; H Skeggs; H Gentner; K C Kwan; C M Martin
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

Review 8.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

9.  Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.

Authors:  H Wallick; D Hendlin
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

10.  Cephaloglycin and its biologically active metabolite desacetylcephaloglycin.

Authors:  W E Wick; W E Wright; H V Kuder
Journal:  Appl Microbiol       Date:  1971-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.